Kevin Herde, Executive VP and CFO at Sorrento Therapeutics, holds 332.91K shares in Maravai Lifesciences Holdings (Ticker: MRVI), holds 4.00K shares in Sorrento Therapeutics (Ticker: SRNE).

See the Hottest Stocks Based on Insider Trading >

Kevin Herde
Sorrento Therapeutics (SRNE)
Executive VP and CFO

Not Ranked

Kevin Herde has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

MRVI

<0.01%

SRNE

A breakdown of Kevin Herde's holdings

See the Top Stocks by Insiders

Insider Roles

Maravai Lifesciences Holdings
(MRVI)

CFO

Sorrento Therapeutics
(SRNE)

Executive VP and CFO

Roles that Kevin Herde holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Sorrento Therapeutics
(SRNE)

Rating:Informative Buy

Date:Feb 03, 2017 - Feb 03, 2018

Return:+50.00%

The most profitable trade made by Kevin Herde

See the Latest Stocks Traded by Insiders

Kevin Herde's Trading History

SRNE

Sorrento Therapeutics

Feb 03, 2017

Executive VP and CFO

Informative Buy

15.45K

$52.00

MRVI

Maravai Lifesciences Holdings

Mar 18, 2024

CFO

Uninformative Sell

66.40K

$2.56M

List of latest transactions for each holding click on a transaction to see Kevin Herde's performance on stock

See All Insider Trading from Today

Kevin Herde insider profile FAQ

What is the percentage of profitable transactions made by Kevin Herde?

The percentage of profitable transactions made by Kevin Herde is ―.

What is the average return per transaction made by Kevin Herde?

The average return per transaction made by Kevin Herde is ―.

What stocks does Kevin Herde hold?

Kevin Herde holds: SRNE, MRVI stocks.

What was Kevin Herde’s latest transaction?

Kevin Herde latest transaction was an Uninformative Sell of $66.40K.

What was Kevin Herde's most profitable transaction?

Kevin Herde’s most profitable transaction was an Informative Buy of SRNE stock on February 3, 2017. The return on the trade was 50.00%.

What is Kevin Herde's role in Sorrento Therapeutics?

Kevin Herde's role in Sorrento Therapeutics is Executive VP and CFO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Kevin Herde Insider Profile

Kevin Herde Sorrento Therapeutics (SRNE)Executive VP and CFO